[IKT] QoQ Quarter Result on 30-Sep-2019 [#Q3]

Stock
[IKT] Inhibikase Therapeutics, Inc.
Announcement Date
29-Sep-2019
Financial Year
2019
Quarter
30-Sep-2019 [#Q3]
Profit Trend
QoQ- 48.29%
YoY-
Quarter Report
IKT's Result
IKT's Financial Summary
View:
Show?
Quarter Result
30/06/20 31/03/20 31/12/19 30/09/19 30/06/19 31/03/19 31/12/18 CAGR
Revenue 220 271 240 124 167 591 1,345 -70.12%
PBT -422 -547 -430 -1,212 -2,344 -1,736 -1,265 -51.93%
Tax -414 -540 -422 -1,205 -2,339 -1,733 0 -
NP -422 -547 -430 -1,212 -2,344 -1,736 -1,265 -51.93%
Tax Rate - - - - - - - -
Total Cost 641 818 670 1,337 2,511 2,327 2,610 -60.81%
Ratio Analysis
30/06/20 31/03/20 31/12/19 30/09/19 30/06/19 31/03/19 31/12/18 CAGR
NP Margin -192.12 -202.17 -178.97 -974.37 -1,404.30 -293.75 -94.02 61.09%
Per Share
30/06/20 31/03/20 31/12/19 30/09/19 30/06/19 31/03/19 31/12/18 CAGR
EPS -0.31 -0.40 -0.32 -0.89 -1.72 -1.27 -0.74 -44.04%
EPS Diluted -0.31 -0.40 -0.32 -0.89 -1.72 -1.27 -0.74 -44.04%

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.